Visit COVID-19 resources

[Skip to Content]

Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents – (Eye 31, 1 (January 2017))

12 January 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login